Clinical Trials

Numerous clinical trials evaluate the therapeutic utility of clindamycin across indications such as bacterial infections, acne vulgaris, cellulitis, prosthetic joint infections, surgical sequelae, and cervical insufficiency. Spanning Early Phase 1 through Phase 4 interventions—including topical gel formulations and periprosthetic joint infection treatments—research is sponsored by academic institutions, hospital networks, and medical centers. Current trial statuses encompass completed studies, actively recruiting protocols, and active non-recruiting trials.

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT07357103 NOT_YET_RECRUITING
Pneumocystis; Pneumocystis Infection; Pneumocystis Carinii Infection; Pneumocystis Carinii; Infection, Resulting From HIV Disease; Pneumocystis Jirovecii Pneumonia; Pneumocystis Jirovecii Infection; Pneumocystosis Associated With AIDS; Pneumocystosis; Pneumonia (Etiology)
McGill University Health Centre/Research Institute of the McGill University Health Centre
 2026-03 PHASE4
NCT07357103 NOT_YET_RECRUITING
Pneumocystis; Pneumocystis Infection; Pneumocystis Carinii Infection; Pneumocystis Carinii; Infection, Resulting From HIV Disease; Pneumocystis Jirovecii Pneumonia; Pneumocystis Jirovecii Infection; Pneumocystosis Associated With AIDS; Pneumocystosis; Pneumonia (Etiology)
McGill University Health Centre/Research Institute of the McGill University Health Centre
 2026-03 PHASE4
NCT05137119 RECRUITING
Staphylococcus Aureus Bacteremia
University of Melbourne
 2022-02-16 PHASE4
NCT05137119 RECRUITING
Staphylococcus Aureus Bacteremia
University of Melbourne
 2022-02-16 PHASE4
NCT06494072 RECRUITING
Community Acquired Pneumonia in Children
Medical College of Wisconsin
 2024-08-22 PHASE4
NCT06494072 RECRUITING
Community Acquired Pneumonia in Children
Medical College of Wisconsin
 2024-08-22 PHASE4
NCT07561541 RECRUITING
Fracture Lower Leg; Diabetes; Fracture Fixation, Internal
Texas Tech University Health Sciences Center, El Paso
 2026-04-01 PHASE4
NCT07561541 RECRUITING
Fracture Lower Leg; Diabetes; Fracture Fixation, Internal
Texas Tech University Health Sciences Center, El Paso
 2026-04-01 PHASE4
NCT07524946 RECRUITING
Acne Vulgaris
Bausch Health Americas, Inc.
 2026-04-01 PHASE4
NCT07524946 RECRUITING
Acne Vulgaris
Bausch Health Americas, Inc.
 2026-04-01 PHASE4
NCT05846399 RECRUITING
Cat Bite; Hand Injuries; Arm Injury; Infection, Bacterial; Anti-bacterial Agents
University of Missouri-Columbia
 2023-09-07 PHASE4
NCT05846399 RECRUITING
Cat Bite; Hand Injuries; Arm Injury; Infection, Bacterial; Anti-bacterial Agents
University of Missouri-Columbia
 2023-09-07 PHASE4
NCT04469075 ACTIVE_NOT_RECRUITING
Glioblastoma; Recurrent Glioblastoma; Skin Toxicity
Memorial Sloan Kettering Cancer Center
 2020-07-09 PHASE2
NCT04469075 ACTIVE_NOT_RECRUITING
Glioblastoma; Recurrent Glioblastoma; Skin Toxicity
Memorial Sloan Kettering Cancer Center
 2020-07-09 PHASE2
NCT06982105 RECRUITING
Methicillin Resistant Staphylococcus Aureus; Osteomyelitis Acute; Septic Arthritis; Orbital Cellulitis; Facial Cellulitis; Mastoiditis; Cervical Adenitis; Retropharyngeal Abscess; Peritonsillar Abscess
Indiana University
 2025-05-20 PHASE4
NCT06982105 RECRUITING
Methicillin Resistant Staphylococcus Aureus; Osteomyelitis Acute; Septic Arthritis; Orbital Cellulitis; Facial Cellulitis; Mastoiditis; Cervical Adenitis; Retropharyngeal Abscess; Peritonsillar Abscess
Indiana University
 2025-05-20 PHASE4
NCT06120140 ACTIVE_NOT_RECRUITING
Carcinoma, Non-Small-Cell Lung
Janssen Research & Development, LLC
 2024-02-16 PHASE2
NCT06120140 ACTIVE_NOT_RECRUITING
Carcinoma, Non-Small-Cell Lung
Janssen Research & Development, LLC
 2024-02-16 PHASE2
NCT07421804 NOT_YET_RECRUITING
Acne Vulgaris
Assiut University
 2026-04
NCT07421804 NOT_YET_RECRUITING
Acne Vulgaris
Assiut University
 2026-04
NCT07504822 NOT_YET_RECRUITING
Acne Vulgaris
Yohanes Firmansyah, dr, MH, MM
 2026-04-18 PHASE1; PHASE2
NCT07504822 NOT_YET_RECRUITING
Acne Vulgaris
Yohanes Firmansyah, dr, MH, MM
 2026-04-18 PHASE1; PHASE2
NCT06172010 RECRUITING
Prosthetic-joint Infection; Infection Hip; Infection; Knee, Joint
Leiden University Medical Center
 2023-04-01 PHASE4
NCT06841003 NOT_YET_RECRUITING
Complicated Appendicitis; Intra-Abdominal Abscess
Spaarne Gasthuis
 2025-02 PHASE3
NCT06172010 RECRUITING
Prosthetic-joint Infection; Infection Hip; Infection; Knee, Joint
Leiden University Medical Center
 2023-04-01 PHASE4
NCT06841003 NOT_YET_RECRUITING
Complicated Appendicitis; Intra-Abdominal Abscess
Spaarne Gasthuis
 2025-02 PHASE3
NCT07663838 NOT_YET_RECRUITING
Randomized; Open-label; Safety; Tolerability; Pharmacokinetics; Bacterial Vaginosis
Changchun GeneScience Pharmaceutical Co., Ltd.
 2026-06-15 PHASE1
NCT07663838 NOT_YET_RECRUITING
Randomized; Open-label; Safety; Tolerability; Pharmacokinetics; Bacterial Vaginosis
Changchun GeneScience Pharmaceutical Co., Ltd.
 2026-06-15 PHASE1
NCT05398679 RECRUITING
Endocarditis Infective
Fundacion Clinic per a la Recerca Biomédica
 2022-08-17 PHASE4
NCT05398679 RECRUITING
Endocarditis Infective
Fundacion Clinic per a la Recerca Biomédica
 2022-08-17 PHASE4
NCT04194216 ENROLLING_BY_INVITATION
Nasal Obstruction; Nasal Surgical Procedures
Stanford University
 2020-05-20 PHASE3
NCT04194216 ENROLLING_BY_INVITATION
Nasal Obstruction; Nasal Surgical Procedures
Stanford University
 2020-05-20 PHASE3
NCT06616168 ACTIVE_NOT_RECRUITING
Bacterial Vaginosis
Danylo Halytsky Lviv National Medical University
 2023-09-01 PHASE1
NCT06616168 ACTIVE_NOT_RECRUITING
Bacterial Vaginosis
Danylo Halytsky Lviv National Medical University
 2023-09-01 PHASE1
NCT07392047 NOT_YET_RECRUITING
Acne Vulgaris
Jinnah Postgraduate Medical Centre
 2026-02 PHASE4
NCT07392047 NOT_YET_RECRUITING
Acne Vulgaris
Jinnah Postgraduate Medical Centre
 2026-02 PHASE4
NCT07267013 RECRUITING
Aortic Surgery; Extracorporeal Circulation
Nantes University Hospital
 2026-04-21 PHASE2
NCT07267013 RECRUITING
Aortic Surgery; Extracorporeal Circulation
Nantes University Hospital
 2026-04-21 PHASE2
NCT06702345 NOT_YET_RECRUITING
C. Difficile; C. Difficile Infection; Controlled Human Infection
Leiden University Medical Center
 2025-03-01
NCT06702345 NOT_YET_RECRUITING
C. Difficile; C. Difficile Infection; Controlled Human Infection
Leiden University Medical Center
 2025-03-01
NCT06787885 COMPLETED
Empyema, Pleural
Fayoum University
 2024-05-01
NCT06787885 COMPLETED
Empyema, Pleural
Fayoum University
 2024-05-01
NCT07474194 RECRUITING
Infection Control / Methods; Surgical Site Infection (SSI)
Beni-Suef University
 2025-09-20 PHASE4
NCT07474194 RECRUITING
Infection Control / Methods; Surgical Site Infection (SSI)
Beni-Suef University
 2025-09-20 PHASE4
NCT05899140 RECRUITING
Skin Infection; Staphylococcal Infections; Staphylococcus Aureus Infection
Frieder Schaumburg
 2024-03-15 PHASE4
NCT05899140 RECRUITING
Skin Infection; Staphylococcal Infections; Staphylococcus Aureus Infection
Frieder Schaumburg
 2024-03-15 PHASE4
NCT05164081 ACTIVE_NOT_RECRUITING
Femoral Neck Fractures; Prosthetic Infection
Umeå University
 2022-01-01 PHASE3
NCT05164081 ACTIVE_NOT_RECRUITING
Femoral Neck Fractures; Prosthetic Infection
Umeå University
 2022-01-01 PHASE3
NCT05867654 UNKNOWN
Osteomyelitis of Jaw
University of Louisville
 2024-07-31 PHASE4
NCT05867654 UNKNOWN
Osteomyelitis of Jaw
University of Louisville
 2024-07-31 PHASE4
NCT04104178 COMPLETED
MRSA; MRSA Colonization
Hvidovre University Hospital
 2020-05-20 PHASE3
NCT04104178 COMPLETED
MRSA; MRSA Colonization
Hvidovre University Hospital
 2020-05-20 PHASE3
NCT01722708 COMPLETED
Abnormal Vaginal Flora; Clindamycin Vs Metronidazole; High Risk Pregnancies for Preterm Labor
HaEmek Medical Center, Israel
 2012-11-01
NCT01722708 COMPLETED
Abnormal Vaginal Flora; Clindamycin Vs Metronidazole; High Risk Pregnancies for Preterm Labor
HaEmek Medical Center, Israel
 2012-11-01
NCT05582434 ACTIVE_NOT_RECRUITING
Acne
Wake Forest University Health Sciences
 2024-02-15 EARLY_PHASE1
NCT05582434 ACTIVE_NOT_RECRUITING
Acne
Wake Forest University Health Sciences
 2024-02-15 EARLY_PHASE1
NCT06336824 UNKNOWN
Staphylococcus Aureus Bacteremia
Clinical Research Centre, Malaysia
 2024-06-28 PHASE3
NCT06336824 UNKNOWN
Staphylococcus Aureus Bacteremia
Clinical Research Centre, Malaysia
 2024-06-28 PHASE3
NCT04502095 COMPLETED
Bladder Carcinoma; Refractory Bladder Carcinoma; Urinary Tract Infection
Roswell Park Cancer Institute
 2020-09-02 PHASE4
NCT04502095 COMPLETED
Bladder Carcinoma; Refractory Bladder Carcinoma; Urinary Tract Infection
Roswell Park Cancer Institute
 2020-09-02 PHASE4
NCT06422221 UNKNOWN
Bacteremia; Endocarditis
University of Santiago de Compostela
 2024-07-15 PHASE4
NCT06422221 UNKNOWN
Bacteremia; Endocarditis
University of Santiago de Compostela
 2024-07-15 PHASE4
NCT03333408 UNKNOWN
Salivary Duct
Our Lady of the Lake Hospital
 2018-06-15 PHASE4
NCT03333408 UNKNOWN
Salivary Duct
Our Lady of the Lake Hospital
 2018-06-15 PHASE4
NCT05849090 COMPLETED
Infections
University of Utah
 2023-03-27 EARLY_PHASE1
NCT05849090 COMPLETED
Infections
University of Utah
 2023-03-27 EARLY_PHASE1
NCT05762484 UNKNOWN
Hidradenitis Suppurativa, Acne Inversa
Erasmus Medical Center
 2023-04
NCT05762484 UNKNOWN
Hidradenitis Suppurativa, Acne Inversa
Erasmus Medical Center
 2023-04
NCT04573504 UNKNOWN
Vaginal Laceration During Delivery
Northwestern University
 2020-09-23 PHASE4
NCT04573504 UNKNOWN
Vaginal Laceration During Delivery
Northwestern University
 2020-09-23 PHASE4
NCT03845790 COMPLETED
Surgical Site Infection
Poitiers University Hospital
 2019-05-26 PHASE1
NCT03845790 COMPLETED
Surgical Site Infection
Poitiers University Hospital
 2019-05-26 PHASE1
NCT06673641 COMPLETED
Acne Vulgaris
Sun Pharmaceutical Industries, Inc.
 2024-05-13 PHASE1
NCT06673641 COMPLETED
Acne Vulgaris
Sun Pharmaceutical Industries, Inc.
 2024-05-13 PHASE1
NCT07247851 COMPLETED
Bacterial Vaginosis
Ain Shams Maternity Hospital
 2024-01-10
NCT07247851 COMPLETED
Bacterial Vaginosis
Ain Shams Maternity Hospital
 2024-01-10
NCT02814916 COMPLETED
Methicillin-Resistant Staphylococcus Aureus; Bacterial Infections; Staphylococcal Skin Infections
AbbVie
 2017-03-30 PHASE3
NCT02814916 COMPLETED
Methicillin-Resistant Staphylococcus Aureus; Bacterial Infections; Staphylococcal Skin Infections
AbbVie
 2017-03-30 PHASE3
NCT02309346 COMPLETED
Septic Abortion
Hospital de Clinicas de Porto Alegre
 2014-12-17 PHASE4
NCT02309346 COMPLETED
Septic Abortion
Hospital de Clinicas de Porto Alegre
 2014-12-17 PHASE4
NCT06068673 COMPLETED
Neurologic Complication; Neurosurgery
Damanhour University
 2023-03-01
NCT06068673 COMPLETED
Neurologic Complication; Neurosurgery
Damanhour University
 2023-03-01
NCT05166746 UNKNOWN
Bacterial Vaginoses; Infertility, Female
Peter Humaidan
 2017-12-07 PHASE2
NCT05166746 UNKNOWN
Bacterial Vaginoses; Infertility, Female
Peter Humaidan
 2017-12-07 PHASE2
NCT05421312 UNKNOWN
PJI; Bone and Joint Infection; Pharmacokinetics
Radboud University Medical Center
 2022-09 PHASE4
NCT05421312 UNKNOWN
PJI; Bone and Joint Infection; Pharmacokinetics
Radboud University Medical Center
 2022-09 PHASE4
NCT03261830 COMPLETED
Supracondylar Humerus Fracture; Post Operative Wound Infection
Sumit Gupta
 2017-08-18 PHASE4
NCT03261830 COMPLETED
Supracondylar Humerus Fracture; Post Operative Wound Infection
Sumit Gupta
 2017-08-18 PHASE4
NCT04723940 UNKNOWN
Joint Infection
Rothman Institute Orthopaedics
 2021-01-25 PHASE3
NCT04723940 UNKNOWN
Joint Infection
Rothman Institute Orthopaedics
 2021-01-25 PHASE3
NCT03945357 COMPLETED
Ventral Hernia Repair
Prisma Health-Upstate
 2019-05-15 PHASE3
NCT03945357 COMPLETED
Ventral Hernia Repair
Prisma Health-Upstate
 2019-05-15 PHASE3
NCT05926869 COMPLETED
Acne Vulgaris
Jinnah Postgraduate Medical Centre
 2022-08-01 PHASE2
NCT05926869 COMPLETED
Acne Vulgaris
Jinnah Postgraduate Medical Centre
 2022-08-01 PHASE2
NCT05177198 UNKNOWN
Periodontal Intrabony Defects
Cairo University
 2022-03
NCT05177198 UNKNOWN
Periodontal Intrabony Defects
Cairo University
 2022-03
NCT05268835 UNKNOWN
Impacted Third Molar Tooth; Impacted Molar
Oral and Maxillofacial Surgery Clinic, Poland
 2020-02-01 PHASE4
NCT05268835 UNKNOWN
Impacted Third Molar Tooth; Impacted Molar
Oral and Maxillofacial Surgery Clinic, Poland
 2020-02-01 PHASE4
NCT05926869 Completed
Acne Vulgaris
Jinnah Postgraduate Medical Centre
 2022-08-01 Phase 2
NCT04933019 UNKNOWN
Staphylococcus Isolates
Sohag University
 2021-07-01 EARLY_PHASE1
NCT04933019 UNKNOWN
Staphylococcus Isolates
Sohag University
 2021-07-01 EARLY_PHASE1
NCT04980170 UNKNOWN
Antibiotics Causing Adverse Effects in Therapeutic Use
Jordan University Hospital
 2021-11-01 EARLY_PHASE1
NCT04980170 UNKNOWN
Antibiotics Causing Adverse Effects in Therapeutic Use
Jordan University Hospital
 2021-11-01 EARLY_PHASE1
NCT05223400 Completed
Infection Bacterial
Alexandria University
 2022-03-01 --
NCT03742908 UNKNOWN
Breast Neoplasms
Tianjin Medical University Cancer Institute and Hospital
 2018-06-16
NCT03742908 UNKNOWN
Breast Neoplasms
Tianjin Medical University Cancer Institute and Hospital
 2018-06-16
NCT03173053 TERMINATED
Staphylococcus Aureus; Motility Disorder
Radboud University Medical Center
 2018-02-08
NCT03173053 TERMINATED
Staphylococcus Aureus; Motility Disorder
Radboud University Medical Center
 2018-02-08
NCT04067531 UNKNOWN
Infection, Bacterial
Skaraborg Hospital
 2020-08-01 PHASE3
NCT04067531 UNKNOWN
Infection, Bacterial
Skaraborg Hospital
 2020-08-01 PHASE3
NCT04035070 UNKNOWN
Necrotic Pulp
Cairo University
 2021-01 PHASE4
NCT04035070 UNKNOWN
Necrotic Pulp
Cairo University
 2021-01 PHASE4
NCT03478163 TERMINATED
Obstetric Complication; Postpartum Hemorrhage; Postpartum Endometritis
Cedars-Sinai Medical Center
 2018-03-08 PHASE4
NCT03478163 TERMINATED
Obstetric Complication; Postpartum Hemorrhage; Postpartum Endometritis
Cedars-Sinai Medical Center
 2018-03-08 PHASE4
NCT04946500 Unknown status
Prosthetic Joint Infection|Staphylococcus
University Hospital Brest
 2021-05-15 --
NCT02809131 COMPLETED
Sick Sinus Syndrome; Complete Heart Block; Syncope; Chronic Systolic Heart Failure
Vanderbilt University Medical Center
 2016-04-01 PHASE3
NCT02809131 COMPLETED
Sick Sinus Syndrome; Complete Heart Block; Syncope; Chronic Systolic Heart Failure
Vanderbilt University Medical Center
 2016-04-01 PHASE3
NCT04370548 COMPLETED
Bacterial Vaginosis
Daré Bioscience, Inc.
 2020-06-16 PHASE3
NCT04370548 COMPLETED
Bacterial Vaginosis
Daré Bioscience, Inc.
 2020-06-16 PHASE3
NCT04516148 COMPLETED
Burn; Surgery; Infection Wound
Medstar Health Research Institute
 2018-05-29 PHASE4
NCT04516148 COMPLETED
Burn; Surgery; Infection Wound
Medstar Health Research Institute
 2018-05-29 PHASE4
NCT03476941 TERMINATED
Abdominal Abscess
University of Iowa
 2019-04-01 PHASE2
NCT03476941 TERMINATED
Abdominal Abscess
University of Iowa
 2019-04-01 PHASE2
NCT04349410 COMPLETED
CoVid 19 Positive
The Camelot Foundation
 2020-04-11 PHASE2; PHASE3
NCT04349410 COMPLETED
CoVid 19 Positive
The Camelot Foundation
 2020-04-11 PHASE2; PHASE3
NCT02585141 COMPLETED
Anal Fistulas
University of Southern Denmark
 2015-10
NCT02585141 COMPLETED
Anal Fistulas
University of Southern Denmark
 2015-10
NCT01792804 COMPLETED
Staphylococcus Aureus Infection
Heinrich-Heine University, Duesseldorf
 2013-12 PHASE3
NCT01792804 COMPLETED
Staphylococcus Aureus Infection
Heinrich-Heine University, Duesseldorf
 2013-12 PHASE3
NCT03560232 TERMINATED
Open Fracture; Post-Op Wound Infection
Mercy Health Ohio
 2018-07-09 PHASE4
NCT03560232 TERMINATED
Open Fracture; Post-Op Wound Infection
Mercy Health Ohio
 2018-07-09 PHASE4
NCT03717506 COMPLETED
Acne Vulgaris
Balmoral Medical company
 2018-10-10 PHASE3
NCT03717506 COMPLETED
Acne Vulgaris
Balmoral Medical company
 2018-10-10 PHASE3
NCT03615768 COMPLETED
Acne Vulgaris
Lee's Pharmaceutical Limited
 2018-08-14 PHASE3
NCT03615768 COMPLETED
Acne Vulgaris
Lee's Pharmaceutical Limited
 2018-08-14 PHASE3
NCT04321070 COMPLETED
Acne Vulgaris
Sun Pharmaceutical Industries, Inc.
 2019-09-09 PHASE1
NCT04321070 COMPLETED
Acne Vulgaris
Sun Pharmaceutical Industries, Inc.
 2019-09-09 PHASE1
NCT03412071 UNKNOWN
Foreskin HIV Susceptibility
University of Toronto
 2017-12-07
NCT03412071 UNKNOWN
Foreskin HIV Susceptibility
University of Toronto
 2017-12-07
NCT03326661 UNKNOWN
Peritonsillar Abscess
Odense University Hospital
 2017-11-10
NCT03326661 UNKNOWN
Peritonsillar Abscess
Odense University Hospital
 2017-11-10
NCT04134273 COMPLETED
Acne Vulgaris
Sun Pharmaceutical Industries, Inc.
 2019-03-20 PHASE1
NCT04134273 COMPLETED
Acne Vulgaris
Sun Pharmaceutical Industries, Inc.
 2019-03-20 PHASE1
NCT03779295 WITHDRAWN
Perioral Dermatitis
West Virginia University
 2018-11-01
NCT03779295 WITHDRAWN
Perioral Dermatitis
West Virginia University
 2018-11-01
NCT03883269 RECRUITING
Acne Vulgaris
Centre for Human Drug Research, Netherlands
 2018-03-20 PHASE4
NCT03883269 RECRUITING
Acne Vulgaris
Centre for Human Drug Research, Netherlands
 2018-03-20 PHASE4
NCT03522441 COMPLETED
Acne Vulgaris
Akorn, Inc.
 2018-04-27 PHASE3
NCT03522441 COMPLETED
Acne Vulgaris
Akorn, Inc.
 2018-04-27 PHASE3
NCT03779360 COMPLETED
Inflammation; Skin
Centre for Human Drug Research, Netherlands
 2018-10-12
NCT03779360 COMPLETED
Inflammation; Skin
Centre for Human Drug Research, Netherlands
 2018-10-12
NCT02782078 COMPLETED
Staphylococcal Infections
Assistance Publique - Hôpitaux de Paris
 2017-03-06
NCT02782078 COMPLETED
Staphylococcal Infections
Assistance Publique - Hôpitaux de Paris
 2017-03-06
NCT02475876 COMPLETED
Bacterial Infections
Michael Cohen-Wolkowiez
 2015-11 PHASE1
NCT02475876 COMPLETED
Bacterial Infections
Michael Cohen-Wolkowiez
 2015-11 PHASE1
NCT03234517 UNKNOWN
Bacterial Vaginosis Treatment
Zagazig University
 2016-08-01 PHASE2
NCT03234517 UNKNOWN
Bacterial Vaginosis Treatment
Zagazig University
 2016-08-01 PHASE2
NCT03122457 COMPLETED
Actinic Keratosis
Icahn School of Medicine at Mount Sinai
 2017-01-01 PHASE2
NCT03122457 COMPLETED
Actinic Keratosis
Icahn School of Medicine at Mount Sinai
 2017-01-01 PHASE2
NCT01874860 COMPLETED
Colorectal Cancer; Head and Neck Cancer
University of Louisville
 2013-08 PHASE2
NCT01874860 COMPLETED
Colorectal Cancer; Head and Neck Cancer
University of Louisville
 2013-08 PHASE2
NCT02674191 UNKNOWN
Orthodontic Anchorage Procedures
Manal El Namrawy
 2016-05
NCT02674191 UNKNOWN
Orthodontic Anchorage Procedures
Manal El Namrawy
 2016-05
NCT02579161 COMPLETED
Kidney Stones
Northwell Health
 2014-09 PHASE3
NCT02579161 COMPLETED
Kidney Stones
Northwell Health
 2014-09 PHASE3
NCT03257202 COMPLETED
Surgical Site Infection
University of Southern California
 2017-09-11 PHASE2
NCT03257202 COMPLETED
Surgical Site Infection
University of Southern California
 2017-09-11 PHASE2
NCT02730962 TERMINATED
Pre-Diabetes
University of Minnesota
 2016-06 PHASE2
NCT02730962 TERMINATED
Pre-Diabetes
University of Minnesota
 2016-06 PHASE2
NCT03033472 UNKNOWN
Symptomatic Periapical Periodontitis
Cairo University
 PHASE2; PHASE3
NCT03033472 UNKNOWN
Symptomatic Periapical Periodontitis
Cairo University
 PHASE2; PHASE3
NCT02860845 COMPLETED
Candidiasis; Vaginosis, Bacterial
Laboratorios Ordesa
 2016-07-12 PHASE4
NCT02860845 COMPLETED
Candidiasis; Vaginosis, Bacterial
Laboratorios Ordesa
 2016-07-12 PHASE4
NCT02593383 COMPLETED
Acne
Lee's Pharmaceutical Limited
 2015-03-01 PHASE1; PHASE2
NCT02593383 COMPLETED
Acne
Lee's Pharmaceutical Limited
 2015-03-01 PHASE1; PHASE2
NCT03080740 UNKNOWN
Bacterial Vaginosis
Guangzhou Yipinhong Pharmaceutical CO.,LTD
 2016-07 PHASE4
NCT03080740 UNKNOWN
Bacterial Vaginosis
Guangzhou Yipinhong Pharmaceutical CO.,LTD
 2016-07 PHASE4
NCT02731105 COMPLETED
Acne Vulgaris
GWT-TUD GmbH
 2015-02 PHASE4
NCT02731105 COMPLETED
Acne Vulgaris
GWT-TUD GmbH
 2015-02 PHASE4
NCT01994993 COMPLETED
Complicated Intra Abdominal Infections
Michael Cohen-Wolkowiez
 2013-12 PHASE2; PHASE3
NCT01994993 COMPLETED
Complicated Intra Abdominal Infections
Michael Cohen-Wolkowiez
 2013-12 PHASE2; PHASE3
NCT01619410 TERMINATED
Skin Diseases, Bacterial; Abscess
University of Chicago
 2012-01
NCT02721173 COMPLETED
Acne Vulgaris
All India Institute of Medical Sciences, Bhubaneswar
 2016-04 PHASE4
NCT01619410 TERMINATED
Skin Diseases, Bacterial; Abscess
University of Chicago
 2012-01
NCT02721173 COMPLETED
Acne Vulgaris
All India Institute of Medical Sciences, Bhubaneswar
 2016-04 PHASE4
NCT02005666 COMPLETED
Acne Vulgaris
Zydus Lifesciences Limited
 2013-11 PHASE3
NCT02005666 COMPLETED
Acne Vulgaris
Zydus Lifesciences Limited
 2013-11 PHASE3
NCT01945450 UNKNOWN
Endometritis
Hadassah Medical Organization
 2014-01
NCT01945450 UNKNOWN
Endometritis
Hadassah Medical Organization
 2014-01
NCT03374176 COMPLETED
Periodontitis; Periodontal Pocket; Diabetes Mellitus
Centro Universitario de Tonalá
 2014-03 PHASE3
NCT03374176 COMPLETED
Periodontitis; Periodontal Pocket; Diabetes Mellitus
Centro Universitario de Tonalá
 2014-03 PHASE3
NCT01800825 COMPLETED
Pregnancy; Prematurity; Preterm Birth; Bacterial Vaginosis
Christiana Care Health Services
 2013-07 PHASE4
NCT01800825 COMPLETED
Pregnancy; Prematurity; Preterm Birth; Bacterial Vaginosis
Christiana Care Health Services
 2013-07 PHASE4
NCT02515305 COMPLETED
Acne
Padagis LLC
 2015-07 PHASE3
NCT02515305 COMPLETED
Acne
Padagis LLC
 2015-07 PHASE3
NCT01757236 UNKNOWN
Hip Prosthetic Joint Infection
University Hospital, Tours
 2012-10 PHASE2
NCT01757236 UNKNOWN
Hip Prosthetic Joint Infection
University Hospital, Tours
 2012-10 PHASE2
NCT02545452 COMPLETED
Endometriosis
Bayer
 2015-09-15 PHASE1
NCT02545452 COMPLETED
Endometriosis
Bayer
 2015-09-15 PHASE1
NCT02198001 UNKNOWN
Bisphosphonate-Associated Osteonecrosis of the Jaw
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
 2014-01
NCT02198001 UNKNOWN
Bisphosphonate-Associated Osteonecrosis of the Jaw
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
 2014-01
NCT01876628 COMPLETED
Cellulitis
University Hospitals Bristol and Weston NHS Foundation Trust
 2013-10 PHASE4
NCT01876628 COMPLETED
Cellulitis
University Hospitals Bristol and Weston NHS Foundation Trust
 2013-10 PHASE4
NCT01715610 WITHDRAWN
Peritonsillar Abscess
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
 2012-05-24
NCT01715610 WITHDRAWN
Peritonsillar Abscess
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
 2012-05-24
NCT02465632 COMPLETED
Acne Vulgaris
Glenmark Pharmaceuticals Ltd. India
 2015-04 PHASE3
NCT02465632 COMPLETED
Acne Vulgaris
Glenmark Pharmaceuticals Ltd. India
 2015-04 PHASE3
NCT02595034 COMPLETED
Acne Vulgaris
Sun Pharmaceutical Industries, Inc.
 2015-01 PHASE1
NCT02595034 COMPLETED
Acne Vulgaris
Sun Pharmaceutical Industries, Inc.
 2015-01 PHASE1
NCT02616614 COMPLETED
Acne Vulgaris
Actavis Inc.
 2015-05 PHASE3
NCT01823523 UNKNOWN
Dentofacial Deformity
Atlantic Center for Oral and Maxillofacial Surgery
 2013-06
NCT02616614 COMPLETED
Acne Vulgaris
Actavis Inc.
 2015-05 PHASE3
NCT01823523 UNKNOWN
Dentofacial Deformity
Atlantic Center for Oral and Maxillofacial Surgery
 2013-06
NCT02578043 COMPLETED
Acne Vulgaris
Sun Pharmaceutical Industries, Inc.
 2015-04 PHASE1
NCT02578043 COMPLETED
Acne Vulgaris
Sun Pharmaceutical Industries, Inc.
 2015-04 PHASE1
NCT02479971 COMPLETED
Pain
Hospital General Universitario Elche
 2014-01 PHASE3
NCT02479971 COMPLETED
Pain
Hospital General Universitario Elche
 2014-01 PHASE3
NCT01269541 COMPLETED
Throatcarriers of MRSA
Region Skane
 2011-03-01
NCT01269541 COMPLETED
Throatcarriers of MRSA
Region Skane
 2011-03-01
NCT02399059 COMPLETED
Colorectal Tumors
Hospital General Universitario Elche
 2011-01 PHASE3
NCT02399059 COMPLETED
Colorectal Tumors
Hospital General Universitario Elche
 2011-01 PHASE3
NCT00730028 COMPLETED
Staphylococcal Infection
National Institute of Allergy and Infectious Diseases (NIAID)
 2009-04 PHASE2
NCT00730028 COMPLETED
Staphylococcal Infection
National Institute of Allergy and Infectious Diseases (NIAID)
 2009-04 PHASE2
NCT02314806 COMPLETED
Breast Cancer
Hospital General Universitario Elche
 2013-01 PHASE3
NCT02196740 UNKNOWN
Periapical Diseases
Lin Jiacheng
 2013-06
NCT02314806 COMPLETED
Breast Cancer
Hospital General Universitario Elche
 2013-01 PHASE3
NCT02196740 UNKNOWN
Periapical Diseases
Lin Jiacheng
 2013-06
NCT02210689 COMPLETED
BACTERIAL VAGINOSIS; Signs and Symptoms to be Evaluated and Recorded Include; Vaginal Discharge Color, Odor, and Consistency; Vulvovaginal Itching and Irritation (Subjective) Absent, Mild, Moderate, or Severe; Vulvovaginal Inflammation (Objective) Absent, Mild, Moderate, or Severe
Actavis Inc.
 2014-01 PHASE3
NCT02210689 COMPLETED
BACTERIAL VAGINOSIS; Signs and Symptoms to be Evaluated and Recorded Include; Vaginal Discharge Color, Odor, and Consistency; Vulvovaginal Itching and Irritation (Subjective) Absent, Mild, Moderate, or Severe; Vulvovaginal Inflammation (Objective) Absent, Mild, Moderate, or Severe
Actavis Inc.
 2014-01 PHASE3
NCT02058628 COMPLETED
Acne Vulgaris
GlaxoSmithKline
 2014-02-21 PHASE4
NCT02058628 COMPLETED
Acne Vulgaris
GlaxoSmithKline
 2014-02-21 PHASE4
NCT01744730 COMPLETED
Bacterial Infections; Obesity
Phillip Brian Smith
 2013-06 PHASE1
NCT01744730 COMPLETED
Bacterial Infections; Obesity
Phillip Brian Smith
 2013-06 PHASE1
NCT01374581 COMPLETED
Malaria
Universiteit Antwerpen
 2012-05 PHASE3
NCT01374581 COMPLETED
Malaria
Universiteit Antwerpen
 2012-05 PHASE3
NCT00911573 WITHDRAWN
Skin Diseases; Infection
Wyeth is now a wholly owned subsidiary of Pfizer
 2011-08 PHASE3
NCT01400867 COMPLETED
Infections, Pediatrics
Forest Laboratories
 2011-12 PHASE2; PHASE3
NCT01400867 COMPLETED
Infections, Pediatrics
Forest Laboratories
 2011-12 PHASE2; PHASE3
NCT00911573 WITHDRAWN
Skin Diseases; Infection
Wyeth is now a wholly owned subsidiary of Pfizer
 2011-08 PHASE3
NCT01915732 COMPLETED
Acne Vulgaris
GlaxoSmithKline
 2013-04 PHASE3
NCT01915732 COMPLETED
Acne Vulgaris
GlaxoSmithKline
 2013-04 PHASE3
NCT02018094 COMPLETED
Wound Infection; Amputation Wound
Hull University Teaching Hospitals NHS Trust
 2013-10-08 PHASE4
NCT02018094 COMPLETED
Wound Infection; Amputation Wound
Hull University Teaching Hospitals NHS Trust
 2013-10-08 PHASE4
NCT02141217 COMPLETED
Focal Infection, Dental
GlaxoSmithKline
 2013-03-21 PHASE4
NCT02141217 COMPLETED
Focal Infection, Dental
GlaxoSmithKline
 2013-03-21 PHASE4
NCT01769235 COMPLETED
Acne Vulgaris
Sun Pharmaceutical Industries, Inc.
 2012-11 PHASE1
NCT01769235 COMPLETED
Acne Vulgaris
Sun Pharmaceutical Industries, Inc.
 2012-11 PHASE1
NCT01769664 COMPLETED
Acne Vulgaris
Sun Pharmaceutical Industries, Inc.
 2012-09 PHASE1
NCT01769664 COMPLETED
Acne Vulgaris
Sun Pharmaceutical Industries, Inc.
 2012-09 PHASE1
NCT00729937 COMPLETED
Staphylococcal Infection
National Institute of Allergy and Infectious Diseases (NIAID)
 2009-04 PHASE2; PHASE3
NCT00729937 COMPLETED
Staphylococcal Infection
National Institute of Allergy and Infectious Diseases (NIAID)
 2009-04 PHASE2; PHASE3
NCT01114516 COMPLETED
Cervical Insufficiency
Northwestern University
 2010-03
NCT01114516 COMPLETED
Cervical Insufficiency
Northwestern University
 2010-03
NCT01796665 COMPLETED
Acne
Padagis LLC
 2012-02 PHASE3
NCT01796665 COMPLETED
Acne
Padagis LLC
 2012-02 PHASE3
NCT01498744 TERMINATED
Abscess Soft Tissue; Methicillin-resistant Staphylococcus Aureus (MRSA) Infection; Skin Abscess
Ann & Robert H Lurie Children's Hospital of Chicago
 2010-02
NCT01498744 TERMINATED
Abscess Soft Tissue; Methicillin-resistant Staphylococcus Aureus (MRSA) Infection; Skin Abscess
Ann & Robert H Lurie Children's Hospital of Chicago
 2010-02
NCT01558388 UNKNOWN
Bacterial Vaginosis
Università degli Studi di Brescia
 2009-09 PHASE4
NCT01788384 COMPLETED
Acne Vulgaris
Watson Laboratories, Inc.
 2012-07 PHASE3
NCT01788384 COMPLETED
Acne Vulgaris
Watson Laboratories, Inc.
 2012-07 PHASE3
NCT00473083 COMPLETED
Rash
British Columbia Cancer Agency
 2009-01 PHASE2
NCT01558388 UNKNOWN
Bacterial Vaginosis
Università degli Studi di Brescia
 2009-09 PHASE4
NCT00473083 COMPLETED
Rash
British Columbia Cancer Agency
 2009-01 PHASE2
NCT01445301 COMPLETED
Acne Vulgaris
GlaxoSmithKline
 2011-09-27 PHASE3
NCT01445301 COMPLETED
Acne Vulgaris
GlaxoSmithKline
 2011-09-27 PHASE3
NCT01155154 TERMINATED
Simple Hand Lacerations
State University of New York - Downstate Medical Center
 2010-02
NCT01155154 TERMINATED
Simple Hand Lacerations
State University of New York - Downstate Medical Center
 2010-02
NCT00814905 WITHDRAWN
Chorioamnionitis
United States Naval Medical Center, Portsmouth
 2008-11-18
NCT00814905 WITHDRAWN
Chorioamnionitis
United States Naval Medical Center, Portsmouth
 2008-11-18
NCT01422785 UNKNOWN
Acne Vulgaris
Zeichner, Joshua, M.D.
 2011-07 PHASE4
NCT01422785 UNKNOWN
Acne Vulgaris
Zeichner, Joshua, M.D.
 2011-07 PHASE4
NCT01500837 COMPLETED
Osteoarticular Infection
Assistance Publique - Hôpitaux de Paris
 2010-10
NCT01448733 UNKNOWN
Acne Vulgaris
Zeichner, Joshua, M.D.
 2011-07 PHASE4
NCT01500837 COMPLETED
Osteoarticular Infection
Assistance Publique - Hôpitaux de Paris
 2010-10
NCT01448733 UNKNOWN
Acne Vulgaris
Zeichner, Joshua, M.D.
 2011-07 PHASE4
NCT01464138 COMPLETED
Malaria
Jomaa Pharma GmbH
 2010-09 PHASE2
NCT01697826 COMPLETED
Vaginal Infections
Dr Bharti Daswani
 2011-04 PHASE4
NCT01361269 UNKNOWN
Malaria
Zentopharm GmbH
 2011-06 PHASE2
NCT01361269 UNKNOWN
Malaria
Zentopharm GmbH
 2011-06 PHASE2
NCT01464138 COMPLETED
Malaria
Jomaa Pharma GmbH
 2010-09 PHASE2
NCT01697826 COMPLETED
Vaginal Infections
Dr Bharti Daswani
 2011-04 PHASE4
NCT01063270 COMPLETED
Hidradenitis Suppurativa
Henry Ford Health System
 2010-02
NCT01063270 COMPLETED
Hidradenitis Suppurativa
Henry Ford Health System
 2010-02
NCT01206348 COMPLETED
Acne
Medicis Global Service Corporation
 2010-09 PHASE4
NCT01206348 COMPLETED
Acne
Medicis Global Service Corporation
 2010-09 PHASE4
NCT00642980 COMPLETED
Pregnancy
University Hospital, Lille
 2006-04 PHASE4
NCT00642980 COMPLETED
Pregnancy
University Hospital, Lille
 2006-04 PHASE4
NCT01231334 COMPLETED
Acne Vulgaris
Allergan
 2010-08 PHASE4
NCT01231334 COMPLETED
Acne Vulgaris
Allergan
 2010-08 PHASE4
NCT01428466 COMPLETED
Acne Vulgaris
GlaxoSmithKline
 2010-11-18 PHASE1
NCT01428466 COMPLETED
Acne Vulgaris
GlaxoSmithKline
 2010-11-18 PHASE1
NCT01293643 COMPLETED
Vaginosis, Bacterial; Candidiasis, Vulvovaginal
Merck Sharp & Dohme LLC
 2010-05 PHASE3
NCT01293643 COMPLETED
Vaginosis, Bacterial; Candidiasis, Vulvovaginal
Merck Sharp & Dohme LLC
 2010-05 PHASE3
NCT01378832 COMPLETED
Surgical Site Infection
Universidad Miguel Hernandez de Elche
 2010-01 PHASE3
NCT01378832 COMPLETED
Surgical Site Infection
Universidad Miguel Hernandez de Elche
 2010-01 PHASE3
NCT01138514 COMPLETED
Acne Vulgaris
Padagis LLC
 2009-10 PHASE3
NCT00823901 COMPLETED
Rosacea
Massachusetts General Hospital
 2009-02 PHASE2; PHASE3
NCT01138514 COMPLETED
Acne Vulgaris
Padagis LLC
 2009-10 PHASE3
NCT01257906 COMPLETED
MILD TO SEVERE ACNE VULGARIS
Actavis Mid-Atlantic LLC
 2010-05
NCT00823901 COMPLETED
Rosacea
Massachusetts General Hospital
 2009-02 PHASE2; PHASE3
NCT01257906 COMPLETED
MILD TO SEVERE ACNE VULGARIS
Actavis Mid-Atlantic LLC
 2010-05
NCT01132443 COMPLETED
Acne Vulgaris
Stiefel, a GSK Company
 2010-05-06 PHASE1
NCT01132443 COMPLETED
Acne Vulgaris
Stiefel, a GSK Company
 2010-05-06 PHASE1
NCT01016977 COMPLETED
Acne Vulgaris
Stiefel, a GSK Company
 2009-10 PHASE4
NCT01016977 COMPLETED
Acne Vulgaris
Stiefel, a GSK Company
 2009-10 PHASE4
NCT01111994 UNKNOWN
Acne
Callender Center for Clinical Research
 2009-11 PHASE4
NCT01111994 UNKNOWN
Acne
Callender Center for Clinical Research
 2009-11 PHASE4
NCT00889356 UNKNOWN
Candidiasis; Bacterial Vaginosis
Zodiac Produtos Farmaceuticos S.A.
 2009-09 PHASE3
NCT00889356 UNKNOWN
Candidiasis; Bacterial Vaginosis
Zodiac Produtos Farmaceuticos S.A.
 2009-09 PHASE3
NCT00838812 COMPLETED
Acne Vulgaris
Igefarma Laboratorios S.A.
 2009-03 PHASE3
NCT00838812 COMPLETED
Acne Vulgaris
Igefarma Laboratorios S.A.
 2009-03 PHASE3
NCT00616330 COMPLETED
Vulvovaginitis; Vaginitis
Lumara Health, Inc.
 2008-01 PHASE3
NCT00616330 COMPLETED
Vulvovaginitis; Vaginitis
Lumara Health, Inc.
 2008-01 PHASE3
NCT01127880 COMPLETED
Hemopneumothorax; Pneumothorax
St. Luke's Hospital, Pennsylvania
 2005-07 PHASE2; PHASE3
NCT01127880 COMPLETED
Hemopneumothorax; Pneumothorax
St. Luke's Hospital, Pennsylvania
 2005-07 PHASE2; PHASE3
NCT00964223 COMPLETED
Acne Vulgaris
Stiefel, a GSK Company
 2009-07 PHASE4
NCT00964223 COMPLETED
Acne Vulgaris
Stiefel, a GSK Company
 2009-07 PHASE4
NCT00694928 COMPLETED
Vaginal Infection
Lumara Health, Inc.
 2008-05 PHASE3
NCT00694928 COMPLETED
Vaginal Infection
Lumara Health, Inc.
 2008-05 PHASE3
NCT01047189 COMPLETED
Acne Vulgaris
Wake Forest University
 2009-03 PHASE4
NCT01047189 COMPLETED
Acne Vulgaris
Wake Forest University
 2009-03 PHASE4
NCT00776919 COMPLETED
Acne Vulgaris
Stiefel, a GSK Company
 2008-10 PHASE3
NCT01015638 COMPLETED
Acne Vulgaris
Stiefel, a GSK Company
 2009-08 PHASE4
NCT00776919 COMPLETED
Acne Vulgaris
Stiefel, a GSK Company
 2008-10 PHASE3
NCT01015638 COMPLETED
Acne Vulgaris
Stiefel, a GSK Company
 2009-08 PHASE4
NCT00964366 COMPLETED
Acne Vulgaris
Stiefel, a GSK Company
 2009-07 PHASE4
NCT00964366 COMPLETED
Acne Vulgaris
Stiefel, a GSK Company
 2009-07 PHASE4
NCT00891982 COMPLETED
Acne Vulgaris
Stiefel, a GSK Company
 2009-04-01 PHASE3
NCT00891982 COMPLETED
Acne Vulgaris
Stiefel, a GSK Company
 2009-04-01 PHASE3
NCT00926367 COMPLETED
Acne Vulgaris
Stiefel, a GSK Company
 2009-05 PHASE4
NCT01052246 COMPLETED
Acne Vulgaris
Laserklinik Karlsruhe
 2008-10
NCT01052246 COMPLETED
Acne Vulgaris
Laserklinik Karlsruhe
 2008-10
NCT00887484 COMPLETED
Acne Vulgaris
Stiefel, a GSK Company
 2009-02 PHASE4
NCT00887484 COMPLETED
Acne Vulgaris
Stiefel, a GSK Company
 2009-02 PHASE4
NCT00926367 COMPLETED
Acne Vulgaris
Stiefel, a GSK Company
 2009-05 PHASE4
NCT00352612 COMPLETED
Staphylococcal Infection; Abscess; Staphylococcal Skin Infection; Folliculitis
Aaron Chen
 2006-09 PHASE4
NCT00352612 COMPLETED
Staphylococcal Infection; Abscess; Staphylococcal Skin Infection; Folliculitis
Aaron Chen
 2006-09 PHASE4
NCT00689117 COMPLETED
Acne Vulgaris; Acne
Stiefel, a GSK Company
 2008-04 PHASE3
NCT00689117 COMPLETED
Acne Vulgaris; Acne
Stiefel, a GSK Company
 2008-04 PHASE3
NCT00713609 COMPLETED
Acne Vulgaris
Stiefel, a GSK Company
 2008-06 PHASE2
NCT00713609 COMPLETED
Acne Vulgaris
Stiefel, a GSK Company
 2008-06 PHASE2
NCT01915758 COMPLETED
Acne Vulgaris
GlaxoSmithKline
 2008-11-21 PHASE1
NCT01915758 COMPLETED
Acne Vulgaris
GlaxoSmithKline
 2008-11-21 PHASE1
NCT01929278 COMPLETED
Acne Vulgaris
Stiefel, a GSK Company
 2008-12-08 PHASE1
NCT01929278 COMPLETED
Acne Vulgaris
Stiefel, a GSK Company
 2008-12-08 PHASE1
NCT01867164 COMPLETED
Vaginitis; Infectious Vaginosis
Janssen-Cilag, S.A.
 2007-12 PHASE3
NCT01867164 COMPLETED
Vaginitis; Infectious Vaginosis
Janssen-Cilag, S.A.
 2007-12 PHASE3
NCT01044264 COMPLETED
Acne Vulgaris
Padagis LLC
 2007-12
NCT01044264 COMPLETED
Acne Vulgaris
Padagis LLC
 2007-12
NCT00372294 UNKNOWN
Chorioretinitis
Shahid Beheshti University of Medical Sciences
 2005-07 PHASE3
NCT00837213 COMPLETED
Acne
Stiefel, a GSK Company
 2007-08 PHASE4
NCT00671749 COMPLETED
Acne Vulgaris
Galderma R&D
 2007-12 PHASE4
NCT00372294 UNKNOWN
Chorioretinitis
Shahid Beheshti University of Medical Sciences
 2005-07 PHASE3
NCT00671749 COMPLETED
Acne Vulgaris
Galderma R&D
 2007-12 PHASE4
NCT00837213 COMPLETED
Acne
Stiefel, a GSK Company
 2007-08 PHASE4
NCT01125410 COMPLETED
Bacterial Vaginosis
Medinova AG
 2007-01 PHASE3
NCT01125410 COMPLETED
Bacterial Vaginosis
Medinova AG
 2007-01 PHASE3
NCT00503542 COMPLETED
Vaginitis
Agency for Healthcare Research and Quality (AHRQ)
 2007-02 EARLY_PHASE1
NCT00503542 COMPLETED
Vaginitis
Agency for Healthcare Research and Quality (AHRQ)
 2007-02 EARLY_PHASE1
NCT00441415 COMPLETED
Acne Vulgaris
Galderma R&D
 2007-02 PHASE3
NCT00441415 COMPLETED
Acne Vulgaris
Galderma R&D
 2007-02 PHASE3
NCT00663286 COMPLETED
Acne Vulgaris
Dow Pharmaceutical Sciences
 2006-10 PHASE3
NCT00663286 COMPLETED
Acne Vulgaris
Dow Pharmaceutical Sciences
 2006-10 PHASE3
NCT00664248 COMPLETED
Acne Vulgaris
Dow Pharmaceutical Sciences
 2006-10 PHASE3
NCT00664248 COMPLETED
Acne Vulgaris
Dow Pharmaceutical Sciences
 2006-10 PHASE3
NCT00836056 COMPLETED
Healthy
Teva Pharmaceuticals USA
 2003-11 PHASE1
NCT00836004 COMPLETED
Healthy
Teva Pharmaceuticals USA
 2003-11 PHASE1
NCT00836004 COMPLETED
Healthy
Teva Pharmaceuticals USA
 2003-11 PHASE1
NCT00836056 COMPLETED
Healthy
Teva Pharmaceuticals USA
 2003-11 PHASE1
NCT00398658 COMPLETED
Endophthalmitis; Prophylaxy of Post Traumatic Endophthalmitis; Bacterial Endophthalmitis
Shahid Beheshti University of Medical Sciences
 2002-03 PHASE4
NCT00214643 COMPLETED
Malaria
Albert Schweitzer Hospital, Netherlands
 2005-06 PHASE3
NCT00000674 COMPLETED
Toxoplasmosis, Cerebral; HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
NCT00217451 COMPLETED
Malaria
Albert Schweitzer Hospital
 2002-06 PHASE2
NCT00361322 COMPLETED
Acne Vulgaris
Hadassah Medical Organization
 2005-04 PHASE1; PHASE2
NCT00214643 COMPLETED
Malaria
Albert Schweitzer Hospital, Netherlands
 2005-06 PHASE3
NCT00000674 COMPLETED
Toxoplasmosis, Cerebral; HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
NCT00217451 COMPLETED
Malaria
Albert Schweitzer Hospital
 2002-06 PHASE2
NCT00361322 COMPLETED
Acne Vulgaris
Hadassah Medical Organization
 2005-04 PHASE1; PHASE2
NCT00000640 COMPLETED
Pneumonia, Pneumocystis Carinii; HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
 PHASE3
NCT00377000 COMPLETED
Acne Vulgaris
Sanofi
 2005-11 PHASE4
NCT00000717 COMPLETED
Pneumonia, Pneumocystis Carinii; HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
NCT01002183 WITHDRAWN
Malaria
Jomaa Pharma GmbH
 PHASE2
NCT00000640 COMPLETED
Pneumonia, Pneumocystis Carinii; HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
 PHASE3
NCT00377000 COMPLETED
Acne Vulgaris
Sanofi
 2005-11 PHASE4
NCT00219570 COMPLETED
Acne Vulgaris
Pfizer
 2005-01 PHASE4
NCT00000717 COMPLETED
Pneumonia, Pneumocystis Carinii; HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
NCT01002183 WITHDRAWN
Malaria
Jomaa Pharma GmbH
 PHASE2
NCT00002064 COMPLETED
Toxoplasmosis, Cerebral; HIV Infections
Palo Alto Medical Foundation
NCT00219570 COMPLETED
Acne Vulgaris
Pfizer
 2005-01 PHASE4
NCT00398658 COMPLETED
Endophthalmitis; Prophylaxy of Post Traumatic Endophthalmitis; Bacterial Endophthalmitis
Shahid Beheshti University of Medical Sciences
 2002-03 PHASE4
NCT00002064 COMPLETED
Toxoplasmosis, Cerebral; HIV Infections
Palo Alto Medical Foundation

(data from https://clinicaltrials.gov, updated on 2026-01-21)

Check the Clindamycin product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.

Compliance for Clinical Use

Mechanism and Biochemical Profile

Clindamycin reversibly binds to the 50S subunit of the bacterial ribosome, thereby inhibiting peptide bond formation and disrupting bacterial protein synthesis. This suppression of essential protein production leads to bacteriostatic inhibition of bacterial growth, supporting its therapeutic efficacy in clinical trials for bacterial infections, acne vulgaris, and joint infections.

Appendix RUO and cGMP Quality Standards

Quality Dimension RUO (Research Use Only) cGMP (Current Good Manufacturing Practice)
Clinical Applicability Prohibited in human clinical trials or medical diagnostics. Mandatory for human clinical trials (Phase I–III) and therapies.
Regulatory Status Non-regulated grade; exempt from drug manufacturing laws. Legally enforced by health authorities (e.g., FDA, EMA, NMPA).
Facility Environment Unclassified analytical or research laboratories. Validated Cleanrooms (ISO Class 5–8) with continuous monitoring.
Quality Control Basic purity and activity testing. Rigorous safety release testing (Sterility, Endotoxin, Mycoplasma).
Process Validation Basic equipment calibration; no process validation required. Full qualification (IQ/OQ/PQ) and complete batch records.
Quality Assurance Vendor self-declared without required formal QMS. Mandatory QA/QC unit, Change Control, CAPA, and vendor audits.
Regulatory Impact High risk of IND rejection if used as a critical raw material. Required for IND/NDA filings, supported by Drug Master Files (DMF).

Footnotes

Regulatory Note: Governed by FDA (21 CFR Parts 210/211/312), EMA (EudraLex Vol 4), ICH Guidelines (E6/Q7/Q9/Q10), and compendial standards (USP <71>/<85>/<1043>).

Jump to

Note: Technical data last updated: Sep 1, 2026.